
Pharmaceutical Sector: M&A Insights 2006-2007
By Neal Ransome – PricewaterhouseCoopers M&A activity proliferates 2006 and the first half of 2007 saw a significant increase in M&A activity in

By Neal Ransome – PricewaterhouseCoopers M&A activity proliferates 2006 and the first half of 2007 saw a significant increase in M&A activity in

By Ragnar van der Valk, Dingenis Blok – PricewaterhouseCoopers, KLM As soon as the deal has been closed the real work starts: the integration. This

Central & Eastern Europe By PricewaterhouseCoopers Executive Summary M&A market value tripled since 2004 In line with the UK and continental

By Tony Edwards, Ali Budjanovcanin and Stuart Woollard – CIPD Summary of key findings This research has been conducted against a backdrop of a

By Ralf C. Schläpfer and Gustav Baldinger. – BearingPoint Cultural differences pose serious business risks for any company engaged in merger and acquisition activity. Alexa

by Towers Perrin
When mergers and acquisitions grab the headlines, it’s often the big deals that move the markets and capture the attention of investors, analysts and the general public. Certainly there have been plenty of blockbuster transactions in recent months as companies loaded with cash have made M&A activity a central part of their quest to build shareholder value. […] Read more

By Accenture In the first half of 2006, Accenture and the Economist Intelligence Unit surveyed senior executives in North America, Europe and Asia on their

by Human Capital Institute
A white paper published by The Human Capital Institute based on a webcast delivered by Mark Arian of Towers Perrin on The Importance of Leadership and Culture to M&A Success. […] Read more

Executive summary: a new era of M&A A new era of M&A has emerged, which is changing the face of corporate
In order to become a charterholder you need to complete one of the IMAA programs